Waterloo Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Waterloo Capital's LLY Position: Q1 2026 in Review
Waterloo Capital reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $504K and leaving 3,663 shares worth $3.37M. The position accounts for 0.24% of the portfolio, ranked #97.
Waterloo Capital first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.47M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Waterloo Capital held 3,663 shares of Eli Lilly worth $3.37M as of Q1 2026.
- Waterloo Capital sold 497 Eli Lilly shares in Q1 2026, an estimated $504K.
- Eli Lilly made up 0.24% of Waterloo Capital's portfolio in Q1 2026, its #97 holding.
- Waterloo Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
- Waterloo Capital's Eli Lilly position peaked at $4.47M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.